List of Tables

Table 1. Geographic Atrophy Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Geographic Atrophy Market Restraints

Table 3. Geographic Atrophy Market Trends

Table 4. Geographic Atrophy Industry Policy

Table 5. Global Geographic Atrophy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Geographic Atrophy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Geographic Atrophy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Geographic Atrophy Mergers & Acquisitions, Expansion Plans

Table 9. Global Geographic Atrophy Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Geographic Atrophy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Geographic Atrophy Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Geographic Atrophy Upstream (Raw Materials)

Table 14. Global Geographic Atrophy Typical Customers

Table 15. Geographic Atrophy Typical Distributors

Table 16. by Type, Global Geographic Atrophy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Geographic Atrophy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Geographic Atrophy Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Geographic Atrophy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Geographic Atrophy Consumption Value Market Share, 2020-2031

Table 23. Apellis Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 24. Apellis Pharmaceuticals Company Profile and Main Business

Table 25. Apellis Pharmaceuticals Geographic Atrophy Models, Specifications, and Application

Table 26. Apellis Pharmaceuticals Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Apellis Pharmaceuticals Recent Developments

Table 28. Iveric Bio Company Information, Head Office, Market Area, and Industry Position

Table 29. Iveric Bio Company Profile and Main Business

Table 30. Iveric Bio Geographic Atrophy Models, Specifications, and Application

Table 31. Iveric Bio Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Iveric Bio Recent Developments

Table 33. Alkeus Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 34. Alkeus Pharmaceuticals Company Profile and Main Business

Table 35. Alkeus Pharmaceuticals Geographic Atrophy Models, Specifications, and Application

Table 36. Alkeus Pharmaceuticals Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Alkeus Pharmaceuticals Recent Developments

Table 38. Hemera Biosciences Company Information, Head Office, Market Area, and Industry Position

Table 39. Hemera Biosciences Company Profile and Main Business

Table 40. Hemera Biosciences Geographic Atrophy Models, Specifications, and Application

Table 41. Hemera Biosciences Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Hemera Biosciences Recent Developments

Table 43. Allegro Ophthalmics Company Information, Head Office, Market Area, and Industry Position

Table 44. Allegro Ophthalmics Company Profile and Main Business

Table 45. Allegro Ophthalmics Geographic Atrophy Models, Specifications, and Application

Table 46. Allegro Ophthalmics Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Allegro Ophthalmics Recent Developments

Table 48. Stealth BioTherapeutics Company Information, Head Office, Market Area, and Industry Position

Table 49. Stealth BioTherapeutics Company Profile and Main Business

Table 50. Stealth BioTherapeutics Geographic Atrophy Models, Specifications, and Application

Table 51. Stealth BioTherapeutics Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. Stealth BioTherapeutics Recent Developments

Table 53. Gyroscope Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 54. Gyroscope Therapeutics Company Profile and Main Business

Table 55. Gyroscope Therapeutics Geographic Atrophy Models, Specifications, and Application

Table 56. Gyroscope Therapeutics Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. Gyroscope Therapeutics Recent Developments

Table 58. Regenerative Patch Technologies Company Information, Head Office, Market Area, and Industry Position

Table 59. Regenerative Patch Technologies Company Profile and Main Business

Table 60. Regenerative Patch Technologies Geographic Atrophy Models, Specifications, and Application

Table 61. Regenerative Patch Technologies Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. Regenerative Patch Technologies Recent Developments

Table 63. Roche Company Information, Head Office, Market Area, and Industry Position

Table 64. Roche Company Profile and Main Business

Table 65. Roche Geographic Atrophy Models, Specifications, and Application

Table 66. Roche Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. Roche Recent Developments

Table 68. Gensight Biologics Company Information, Head Office, Market Area, and Industry Position

Table 69. Gensight Biologics Company Profile and Main Business

Table 70. Gensight Biologics Geographic Atrophy Models, Specifications, and Application

Table 71. Gensight Biologics Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 72. Gensight Biologics Recent Developments

Table 73. NGM Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 74. NGM Biopharmaceuticals Company Profile and Main Business

Table 75. NGM Biopharmaceuticals Geographic Atrophy Models, Specifications, and Application

Table 76. NGM Biopharmaceuticals Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 77. NGM Biopharmaceuticals Recent Developments

Table 78. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 79. AstraZeneca Company Profile and Main Business

Table 80. AstraZeneca Geographic Atrophy Models, Specifications, and Application

Table 81. AstraZeneca Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 82. AstraZeneca Recent Developments

Table 83. Lineage Cell Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 84. Lineage Cell Therapeutics Company Profile and Main Business

Table 85. Lineage Cell Therapeutics Geographic Atrophy Models, Specifications, and Application

Table 86. Lineage Cell Therapeutics Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 87. Lineage Cell Therapeutics Recent Developments

Table 88. Allergan Company Information, Head Office, Market Area, and Industry Position

Table 89. Allergan Company Profile and Main Business

Table 90. Allergan Geographic Atrophy Models, Specifications, and Application

Table 91. Allergan Geographic Atrophy Revenue and Gross Margin, US$ Million, 2020-2025

Table 92. Allergan Recent Developments

List of Figures

Figure 1. Geographic Atrophy Picture

Figure 2. Global Geographic Atrophy Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Geographic Atrophy Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Geographic Atrophy Market Share of Global, 2020-2031

Figure 5. Global Geographic Atrophy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Geographic Atrophy Key Participants, Market Share, 2024

Figure 7. Geographic Atrophy Industry Chain

Figure 8. Geographic Atrophy Procurement Model

Figure 9. Geographic Atrophy Sales Model

Figure 10. Geographic Atrophy Sales Channels, Direct Sales, and Distribution

Figure 11. Above 60 Years

Figure 12. Above 75 Years

Figure 13. by Type, Global Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 14. by Type, Global Geographic Atrophy Consumption Value Market Share, 2020-2031

Figure 15. Late-stage (Phase III)

Figure 16. Phase II

Figure 17. Phase I

Figure 18. Pre-clinical stage

Figure 19. by Application, Global Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 20. by Application, Global Geographic Atrophy Revenue Market Share, 2020-2031

Figure 21. By Region, Global Geographic Atrophy Consumption Value Market Share, 2020-2031

Figure 22. North America Geographic Atrophy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 23. By Country, North America Geographic Atrophy Consumption Value Market Share, 2024

Figure 24. Europe Geographic Atrophy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 25. By Country, Europe Geographic Atrophy Consumption Value Market Share, 2024

Figure 26. Asia Pacific Geographic Atrophy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 27. By Country/Region, Asia Pacific Geographic Atrophy Consumption Value Market Share, 2024

Figure 28. South America Geographic Atrophy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 29. By Country, South America Geographic Atrophy Consumption Value Market Share, 2024

Figure 30. Middle East & Africa Geographic Atrophy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 31. United States Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 32. by Type, United States Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 33. by Application, United States Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 34. Europe Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 35. by Type, Europe Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 36. by Application, Europe Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 37. China Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 38. by Type, China Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 39. by Application, China Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 40. Japan Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 41. by Type, Japan Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 42. by Application, Japan Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 43. South Korea Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 44. by Type, South Korea Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 45. by Application, South Korea Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 46. Southeast Asia Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 47. by Type, Southeast Asia Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 48. by Application, Southeast Asia Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 49. India Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 50. by Type, India Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 51. by Application, India Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 52. Middle East & Africa Geographic Atrophy Consumption Value, 2020-2031, US$ Million

Figure 53. by Type, Middle East & Africa Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 54. by Application, Middle East & Africa Geographic Atrophy Consumption Value Market Share, 2024 VS 2031

Figure 55. Research Methodology

Figure 56. Breakdown of Primary Interviews

Figure 57. Bottom-up Approaches

Figure 58. Top-down Approaches